Home Report Store Insulin Pens Market

Insulin Pens Market Size, Share, Forecast, & Trends Analysis by Type (Disposable, Reusable, Smart [Bluetooth, NFC]) Diabetes Type (Type 1, Type 2) Distribution (Hospital, Retail Pharmacies, E-commerce) Healthcare Setting - Global Forecast to 2031

Report ID:MRHC - 1041206 Pages: 220 May-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours

The Insulin Pens Market was valued at $4.03 billion in 2023. This market is expected to reach $6.73 billion by 2031, from an estimated $4.28 billion in 2024, at a CAGR of 6.7% during the forecast period 2024-2031.

Insulin Pens Market Size & Forecast

The growth of this market can be attributed to several factors, including the increasing prevalence of diabetes, technological advancements in insulin pens, increasing demand for self-administration of drugs, and rising diabetes awareness programs. Moreover, rising preference for insulin pens over vials and syringes, emerging economies, and partnerships and collaborations between the companies are expected to offer growth opportunities for the players operating in this market.

Insulin Pens Market Growth Drivers

Increasing Prevalence of Diabetes

Diabetes stands as one of the foremost global health challenges in the 21st century, with its prevalence increasing annually and posing significant risks of life-altering complications. According to the International Diabetes Federation, in 2021, 537 million people were diagnosed with diabetes worldwide. Among these, the Western Pacific region accounted for 206 million cases, Southeast Asia for 90 million, the Middle East and North Africa for 73 million, Europe for 61 million, North America and the Caribbean for 51 million, South and Central America for 32 million, and Africa for 24 million. This number is projected to reach 643 million by 2030 and 783 million by 2045.

Moreover, the Centers for Disease Control and Prevention reported that in 2022, 38 million individuals were diagnosed with diabetes in the U.S. Furthermore, Type 2 diabetes is increasingly prevalent among adults aged 45 and above, while its occurrence is also rising among teenagers, children, and adults overall. Thus, the rising prevalence of diabetes is driving the growth of the insulin pens market.

Insulin Pens Market Click here to: Get a Free Sample Copy of this Report

Increasing Diabetes Awareness Programs

Various organizations have launched diabetes awareness programs that aim to educate the public about diabetes, its management, and the importance of early detection and management. These programs often highlight the various options available for managing diabetes, including insulin pens. For instance,

In December 2023, Goa State partnered with Sanofi S.A. (France) to initiate an education and awareness program about diabetes in schools.
In November 2023, F. Hoffmann-La Roche Ltd (Switzerland) collaborated with public and private stakeholders in the Indian healthcare system to boost awareness and education about the early diagnosis of diabetes.
In June 2023, Eli Lilly and Company (U.S.) partnered with the American Diabetes Association (ADA) and Adam Duvall, an American professional baseball player, to increase awareness of insulin affordability solutions for all people living with diabetes in the U.S.

Thus, increasing diabetes awareness and care programs is expected to drive the demand for insulin pens.

Insulin Pens Market Opportunities

Partnerships and Collaborations

Various public-private organizations are focusing on partnerships and collaborations due to the increasing demand for insulin pens due to their dose precision and accuracy, and to minimize the risk of needle stick injuries. For instance,

In October 2022, BIOCORP Production (France) partnered with Merck & Co., Inc. (U.S.) for insulin pen injectors that use Bluetooth to collect and transmit information, including the quantity and duration of each administration with the company's software.
In September 2021, BIOCORP Production (France) partnered with Novo Nordisk A/S (Denmark) to distribute and develop the Novo Nordisk FlexTouch pen, which is used by people with diabetes.
In March 2021, Diabeloop SA (France) collaborated with Novo Nordisk A/S (Denmark) to integrate Novo Nordisk’s new generation of connected pens, NovoPen 6 and NovoPen Echo Plus, with DBL-4pen.

Thus, increasing partnerships and collaborations between the companies creates an opportunity for the insulin pens market.

Rising Preference for Insulin Pens over Vials and Syringes

Insulin pens are more comfortable and easier to use than vials and syringes. They are portable and come pre-filled with insulin, which avoids the necessity to draw and measure doses manually. This procedure makes insulin delivery easier, particularly for people with disabilities who need help with injections.

In addition, insulin pens come with disposable needles that are easy to remove and attach. This removes the need for needle reuse and minimizes the danger of needlestick injuries, resulting in faster insulin administration. This is particularly significant for doctors who often provide insulin injections to several individuals. Furthermore, insulin pens enable a more precise and accurate dosage than vials and syringes. Insulin pens usually have clear dosage indicators and finer dose increment alternatives, which enable improved insulin delivery. This accuracy is especially crucial for people who have unique insulin needs or who must deliver small or variable amounts of insulin. These are the factors that create opportunities for the market players in the insulin pens market.

Insulin Pens Market Trends

Smart Insulin Pens

Smart insulin pens use wireless technologies and Bluetooth to link to cell phones and other devices. This connection allows customers to monitor and track their scheduled injections and insulin doses and transfer information with diabetes management apps and cloud-based systems. The capacity to digitize insulin dose data delivers useful insights to doctors and patients, allowing for better diabetes control.

In addition, smart insulin pens often include dosage calculation functions, which allow patients to customize their sensitivity to insulin, consumption of carbohydrates, and target blood glucose levels. The pen uses these factors to compute the right insulin dose, lowering the possibility of dosing errors. Furthermore, various companies are launching smart insulin pens. For instance, in March 2022, Novo Nordisk A/S (Denmark) launched the NovoPen 6 and NovoPen Echo Plus, smart connected insulin pens to treat diabetes in the U.K.

Insulin Pens Market Analysis: Key Findings

By Type: In 2024, the Disposable Insulin Pens Segment to Dominate the Insulin Pens Market

Based on Type, the insulin pens market is segmented into disposable insulin pens, reusable insulin pens, and smart insulin pens. In 2024, the disposable insulin pens segment is expected to account for the largest share of 58.1% of the insulin pens market. The large market share of this segment can be attributed to the benefits offered by the disposable insulin pens, such as being less painful, coming with a prefilled insulin cartridge preloaded in the pen, and the entire product being discarded after the cartridge is finished, and minimizing the chances of infections. Furthermore, owing to the rising demand for insulin pens, companies operating in this market are focusing on the introduction, approvals, and innovative offerings. For instance, in January 2024, BIOCORP Production (France) received 510(K)-clearance approval from the U.S. Food & Drug Administration (FDA) to market the SoloSmart disposable insulin pens.

This segment is also projected to register the highest CAGR of 7.0% during the forecast period of 2024-2031.

By Application: In 2024, the Type 1 Diabetes Segment to Dominate the Insulin Pens Market

Based on application, the insulin pens market is segmented into type 1 diabetes and type 2 diabetes. In 2024, the type 1 diabetes segment is expected to account for the larger share of the insulin pens market. The large market share can be attributed to the increasing number of insulin-dependent patients and the rising number of type 1 diabetes cases. For instance, according to the International Diabetes Federation (IDF) data, in 2022, 8.75 million lived with type 1 diabetes globally. Out of which 1.52 million of these people were under 20 years old. Thus, the increasing number of type 1 diabetes cases drives the growth of this segment.

By Distribution Channel: The Retail Pharmacies Segment to Dominate the Insulin Pens Market

Based on distribution channel, the insulin pens market is segmented into hospital pharmacies, retail pharmacies, and online/e-commerce platforms. In 2024, the retail pharmacies segment is expected to account for the largest share of the insulin pens market. The large market share of this segment can be attributed to the increasing consumer demand for insulin pens and the opportunity for customers to inspect the product before making a purchase.

By Healthcare Setting: The Home Care Segment to Dominate the Insulin Pens Market

Based on healthcare setting, the insulin pens market is segmented into home care, hospitals & clinics, and long-term care settings. In 2024, the home care segment is expected to account for the largest share of 51.2% of the insulin pens market. The large market share of this segment can be attributed to the increasing development and adoption of home care devices due to their convenience, precision, and accuracy. Additionally, there has been a growing focus among companies to raise awareness about diabetes, which has led to increased adoption of insulin pens in home care settings. Furthermore, home care allows patients to receive the necessary care for managing their conditions in the comfort of their own homes. Insulin pens play a crucial role in enabling patients to self-administer injectable medications, further driving the shift toward home care.

This segment is also projected to register the fastest CAGR of 7.2% during the forecast period of 2024-2031.

Geographical Analysis

In 2024, North America is expected to account for the largest share of 37.8% of the insulin pens market, followed by Europe and Asia-Pacific. North America’s significant market share can be attributed to several key factors, including the presence of major insulin pens companies such as Eli Lilly and Company (U.S.) and Becton, Dickinson and Company (U.S.), increasing healthcare expenditure, rising demand for self-administration of drugs, and rising number of diabetes cases in this region are some of the major factors driving the growth of the region.

Moreover, the market in Asia-Pacific is slated to register the highest growth rate of 7.5% during the forecast period. The growth of this regional market is attributed to the growing awareness regarding insulin pens, increasing awareness programs regarding diabetes in countries such as China and India, and growing healthcare infrastructure.

Insulin Pens Market: Key Companies

The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted in the last 3–4 years. Some of the key players operating in the insulin pens market are Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Biocon Limited (India), Becton, Dickinson and Company (U.S.), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), Medtronic plc (Ireland), Emperra GmbH E-Health Technologies (Germany), pendiq GmbH (Germany), and Jiangsu Delfu medical device Co., Ltd. (China).

Insulin Pens Industry Overview: Latest Developments from Key Industry Players

In February 2023 , Innovation Zed Ltd. (Ireland) received CE mark approval in Europe for its InsulCheck Dose, an insulin pen that offers real-time injection event data and delivers it to a matching display device.
In November 2020 , Medtronic plc (Ireland) launched the InPen integrated with real-time Guardian Connect CGM data, a smart insulin pen for people with diabetes on multiple daily injections (MDI).

Insulin Pens Market: Research Summary

Particulars	Details
Number of Pages	220
Format	PDF
Forecast Period	2024–2031
Base Year	2023
CAGR (Value)	6.7%
Market Size (Value)	USD 6.73 billion by 2031
Segments Covered	By Type Disposable Insulin Pens Reusable Insulin Pens Smart Insulin Pens Bluetooth Connectivity Near Field Communication (NFC) Connectivity By Application Type 1 Diabetes Type 2 Diabetes By Distribution Channel Hospital Pharmacies Retail Pharmacies Online/E-commerce Platforms By Healthcare Setting Home Care Hospitals & Clinics Long-Term Care Settings
Countries Covered	North America (U.S., Canada), Europe (Germany, France, Italy, U.K., Spain, Austria, Netherlands, Rest of Europe) Asia–Pacific (India, China, Japan, Australia, South Korea, Rest of Asia–Pacific), Latin America (Brazil, Mexico, Rest of Latin America), Middle East & Africa.
Key Companies	Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Biocon Limited (India), Becton, Dickinson and Company (U.S.), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), Medtronic plc (Ireland), Emperra GmbH E-Health Technologies (Germany), pendiq GmbH (Germany), and Jiangsu Delfu medical device Co., Ltd (China).

Key questions answered in the insulin pens market report:

What is the focus of the insulin pens market study?

This study offers a detailed assessment of the insulin pens market sizes & forecasts based on type, application, distribution channel, and healthcare setting. This report also involves the value analysis of various segments and subsegments of the insulin pens market at the regional and country levels.

What is the size of the insulin pens market, and at what CAGR is this market projected to grow during 2024–2031?

The insulin pens market is projected to reach $6.73 billion by 2031, at a CAGR of 6.7% during the forecast period.

Which product is expected to hold the major share of the market in 2024?

Among the types covered in this report, in 2024, the disposable insulin pens segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the benefits offered by disposable insulin pens and advancements in insulin pens.

Which application segment is expected to hold the largest share of the market in 2024?

Among the applications covered in this report, in 2024, the type 1 diabetes segment is expected to account for the largest share of the insulin pens market. The large market share of this segment can be attributed to the increasing number of type 1 diabetes cases and increasing diabetes awareness programs are the factors contributing to the significant market share of this segment.

What are the key factors supporting the growth of this market? What are the major opportunities for existing market players and new entrants in the insulin pens market?

The growth of this market can be attributed to several factors, including the increasing prevalence of diabetes, technological advancements in insulin pens, increasing demand for self-administration of drugs, and increasing diabetes awareness programs. Moreover, rising preference for insulin pens over vials and syringes, emerging economies, and partnerships and collaborations between the companies are expected to offer growth opportunities for the players operating in this market.

Who are the major players operating in the insulin pens market?

The key players profiled in the insulin pens market report are Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Biocon Limited (India), Becton, Dickinson and Company (U.S.), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), Medtronic plc (Ireland), Emperra GmbH E-Health Technologies (Germany), pendiq GmbH (Germany), and Jiangsu Delfu medical device Co., Ltd (China).

Which regions/countries are likely to offer significant growth opportunities for the vendors in this market during the analysis period?

Emerging economies, such as China and India, are expected to provide significant growth opportunities for market players due to the growing awareness of diabetes, increasing demand for self-administration of drugs, and increasing number of diabetes cases in these countries.

Enquire

Check Discount

Related Tag: Insulin Pens Insulin Pen Injector Reusable Insulin Pens Insulin Delivery Devices Injector Pens Disposable Insulin Pens Smart Insulin Pens Connected Insulin Pens Insulin Delivery Pens Insulin Pens Market

Medical Technologies

Healthcare

1.   Introduction
1.1.   Market Definition & Scope
1.2.   Market Ecosystem
1.3.   Currency & Limitations
1.4.   Key Stakeholders
2.   Research Methodology
2.1.   Research Approach
2.2.   Process of Data Collection & Validation
2.2.1.   Secondary Research
2.2.2.   Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3.   Market Sizing and Forecasting
2.3.1.   Market Size Estimation Approach
2.3.2.   Growth Forecast Approach
2.3.3.   Market Share Analysis
2.4.   Assumptions for the Study
3.   Executive Summary
4.   Factors Affecting Market Growth
4.1.   Overview
4.2.   Drivers
4.2.1.   Increasing Prevalence of Diabetes
4.2.2.   Technological Advancements in Insulin Pens
4.2.3.   Rising Demand for Self-Administration of Drugs
4.2.4   Rising Diabetes Awareness Programs
4.3.   Restraints
4.3.1.   High Cost of Insulin Pens
4.3.2.   Availability of Alternatives to Insulin Pens
4.3.3.   Needle Anxiety in Patients
4.4.   Opportunities
4.4.1.   Rising Preference for Insulin Pens over Vials and Syringes
4.4.2.   Emerging Economies
4.4.3.   Partnerships and Collaborations
4.5.   Challenges
4.5.1.   Lack of Awareness and Knowledge in Developing Countries
4.5.2.   Limited Access to Healthcare in Developing Countries
4.6.   Trends
4.6.1.   Smart Insulin Pens
4.6.2.   Prefilled Insulin Pens
4.7.   Factor Analysis
4.8.   Regulatory Analysis
4.8.1.   U.S.
4.8.2.   Canada
4.8.3.   Europe
4.8.4.   China
4.8.5.   Japan
4.8.6.   India
4.8.7.   Latin America
4.8.8.   Middle East
4.9.   Pricing Analysis
4.10.   Parent/Adjacent Market Analysis
4.11.   Porter’s Five Forces Analysis
5.   Insulin Pens Market Assessment—by Type
5.1.   Overview
5.2.   Disposable Insulin Pens
5.3.   Reusable Insulin Pens
5.4.   Smart Insulin Pens
5.4.1.   Bluetooth Connectivity
5.4.2.   Near Field Communication (NFC) Connectivity
6.   Insulin Pens Market Assessment—by Application
6.1.   Overview
6.2.   Type 1 Diabetes
6.3.   Type 2 Diabetes
7.   Insulin Pens Market Assessment—by Distribution Channel
7.1.   Overview
7.2.   Hospital Pharmacies
7.3.   Retail Pharmacies
7.4.   Online/E-commerce Platforms
8.   Insulin Pens Market Assessment—by Healthcare Setting
8.1.   Overview
8.2.   Home Care
8.3.   Hospitals & Clinics
8.4.   Long-Term Care Settings
9.   Insulin Pens Market Assessment—by Geography
9.1.   Overview
9.2.   North America
9.2.1.   U.S.
9.2.2.   Canada
9.3.   Europe
9.3.1.   Germany
9.3.2.   France
9.3.3.   U.K.
9.3.4.   Italy
9.3.5.   Spain
9.3.6.   Austria
9.3.7.   Netherlands
9.3.8.   Rest of Europe
9.4.   Asia-Pacific
9.4.1.   Japan
9.4.2.   China
9.4.3.   India
9.4.4.   Australia
9.4.5.   South Korea
9.4.6.   Rest of Asia-Pacific
9.5.   Latin America
9.5.1.   Brazil
9.5.2.   Mexico
9.5.3.   Rest of Latin America
9.6.   Middle East & Africa
10. Competition Analysis
10.1.   Overview
10.2.   Key Growth Strategies
10.3.   Competitive Benchmarking
10.4.   Competitive Dashboard
10.4.1.   Industry Leaders
10.4.2.   Market Differentiators
10.4.3.   Vanguards
10.4.4.   Emerging Companies
10.5.   Market Share Analysis/Market Rankings of Key Players (2023)
11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1.   Novo Nordisk A/S
11.2.   Eli Lilly and Company
11.3.   Sanofi S.A.
11.4.   Biocon Limited
11.5.   Becton, Dickinson and Company
11.6.   Ypsomed AG
11.7.   Owen Mumford Limited
11.8.   Medtronic plc
11.9.   Emperra GmbH E-Health Technologies
11.10.   pendiq GmbH
11.11.   Jiangsu Delfu medical device Co. Ltd
(Note: SWOT analysis of the top 5 companies will be provided.)
12.   Appendix
12.1.   Available Customization
12.2.   Related Reports

List of Tables
Table 1 Global Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 2 Global Disposable Insulin Pens Market, by Country/Region , 2022–2031 (USD Million)
Table 3 Global Disposable Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Reusable Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 6 Global Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Bluetooth Connected Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Near Field Communication (NFC) Smart Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 10   Global Insulin Pens Market for Type 1 Diabetes, by Country/Region, 2022–2031 (USD Million)
Table 11   Global Insulin Pens Market for Type 2 Diabetes, by Country/Region, 2022–2031 (USD Million)
Table 12   Global Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 13   Global Insulin Pens Market for Hospital Pharmacies, by Country/Region, 2022–2031 (USD Million)
Table 14   Global Insulin Pens Market for Retail Pharmacies, by Country/Region, 2022–2031 (USD Million)
Table 15   Global Insulin Pens Market for Online/E-commerce Platforms, by Country/Region, 2022–2031 (USD Million)
Table 16   Global Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 17   Global Insulin Pens Market for Home Care, by Country/Region, 2022–2031 (USD Million)
Table 18   Global Insulin Pens Market for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 19   Global Insulin Pens Market for Long-Term Care Settings, by Country/Region, 2022–2031 (USD Million)
Table 20   Global Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 21   North America: Insulin Pens Market, by Country, 2022–2031 (USD Million)
Table 22   North America: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 23   North America: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 24   North America: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 25   North America: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 26   North America: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 27   U.S.: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 28   U.S.: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 29   U.S.: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 30   U.S.: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 31   U.S.: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 32   Canada: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 33   Canada: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 34   Canada: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 35   Canada: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 36   Canada: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 37   Europe: Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 38   Europe: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 39   Europe: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 40   Europe: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 41   Europe: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 42   Europe: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 43   Germany: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 44   Germany: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 45   Germany: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 46   Germany: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 47   Germany: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 48   France: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 49   France: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 50   France: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 51   France: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 52   France: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 53   Italy: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 54   Italy: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 55   Italy: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 56   Italy: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 57   Italy: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 58   Spain: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 59   Spain: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 60   Spain: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 61   Spain: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 62   Spain: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 63   Austria: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 64   Austria: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 65   Austria: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 66   Austria: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 67   Austria: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 68   Netherlands: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 69   Netherlands: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 70   Netherlands: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 71   Netherlands: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 72   Netherlands: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 73   Rest of Europe: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 74   Rest of Europe: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 75   Rest of Europe: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 76   Rest of Europe: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 77   Rest of Europe: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 78   Asia-Pacific: Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 79   Asia-Pacific: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 80   Asia-Pacific: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 81   Asia-Pacific: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 82   Asia-Pacific: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 83   Asia-Pacific: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 84   China: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 85   China: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 86   China: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 87   China: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 88   China: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 89   Japan: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 90   Japan: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 91   Japan: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 92   Japan: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 93   Japan: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 94   India: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 95   India: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 96   India: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 97   India: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 98   India: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 99   South Korea: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 100   South Korea: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 101   South Korea: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 102   South Korea: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 103   South Korea: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 104   Australia: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 105   Australia: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 106   Australia: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 107   Australia: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 108   Australia: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 109   Rest of Asia-Pacific: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 110   Rest of Asia-Pacific: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 111   Rest of Asia-Pacific: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 112   Rest of Asia-Pacific: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 113   Rest of Asia-Pacific: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 114   Latin America: Insulin Pens Market, by Country/Region, 2022–2031 (USD Million)
Table 115   Latin America: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 116   Latin America: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 117   Latin America: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 118   Latin America: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 119   Latin America: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 120   Brazil: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 121   Brazil: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 122   Brazil: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 123   Brazil: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 124   Brazil: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 125   Mexico: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 126   Mexico: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 127   Mexico: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 128   Mexico: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 129   Mexico: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 130   Rest of Latin America: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 131   Rest of Latin America: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 132   Rest of Latin America: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 133   Rest of Latin America: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 134   Rest of Latin America: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 135   Middle East & Africa: Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 136   Middle East & Africa: Smart Insulin Pens Market, by Type, 2022–2031 (USD Million)
Table 137   Middle East & Africa: Insulin Pens Market, by Application, 2022–2031 (USD Million)
Table 138   Middle East & Africa: Insulin Pens Market, by Distribution Channel, 2022–2031 (USD Million)
Table 139   Middle East & Africa: Insulin Pens Market, by Healthcare Setting, 2022–2031 (USD Million)
Table 140   Recent Developments, by Company, 2020–2024

List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Insulin Pens Market, by Type, 2024 VS. 2031 (USD Million)
Figure 8 Global Insulin Pens Market, by Application, 2024 VS. 2031 (USD Million)
Figure 9 Global Insulin Pens Market, by Distribution Channel, 2024 VS. 2031 (USD Million)
Figure 10   Global Insulin Pens Market, by Healthcare Setting, 2024 VS. 2031 (USD Million)
Figure 11   Global Insulin Pens Market, by Geography
Figure 12   Impact Analysis: Insulin Pens Market
Figure 13   Global Insulin Pens Market, by Type, 2024 VS. 2031 (USD Million)
Figure 14   Global Insulin Pens Market, by Application, 2024 VS. 2031 (USD Million)
Figure 15   Global Insulin Pens Market, by Distribution Channel, 2024 VS. 2031 (USD Million)
Figure 16   Global Insulin Pens Market, by Healthcare Setting, 2024 VS. 2031 (USD Million)
Figure 17   Global Insulin Pens Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 18   North America: Insulin Pens Market Snapshot
Figure 19   Europe: Insulin Pens Market Snapshot
Figure 20   Asia-Pacific: Insulin Pens Market Snapshot
Figure 21   Latin America: Insulin Pens Market Snapshot
Figure 22   Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 23   Global Insulin Pens Market: Competitive Benchmarking, by Type
Figure 24   Global Insulin Pens Market: Competitive Benchmarking, by Geography
Figure 25   Global Insulin Pens Market: Competitive Dashboard
Figure 26   Global Insulin Pens Market: Market Share Analysis/Market Ranking By Key Players, 2023
Figure 27   Novo Nordisk A/S: Financial Overview (2023)
Figure 28   Eli Lilly and Company: Financial Overview (2023)
Figure 29   Sanofi S.A.: Financial Overview (2023)
Figure 30   Biocon Limited: Financial Overview (2023)
Figure 31   Becton, Dickinson and Company: Financial Overview (2023)
Figure 32   Ypsomed AG: Financial Overview (2023)
Figure 33   Medtronic plc: Financial Overview (2023)

Enquire

Check Discount

Author Name:

Madhura Pawar, Mahesh Khillari

Medical Technologies

Healthcare

This website is secure and we do not share your personal information with any third party. privacy policy

Proudly Partnering With Enterprises Around the Globe

Request Sample

Customize My Report

Quick Contact

Chat on Whatsapp

Insulin Pens Market Size, Share, Forecast, & Trends Analysis by Type (Disposable, Reusable, Smart [Bluetooth, NFC]) Diabetes Type (Type 1, Type 2) Distribution (Hospital, Retail Pharmacies, E-commerce) Healthcare Setting - Global Forecast to 2031

The Insulin Pens Market was valued at $4.03 billion in 2023. This market is expected to reach $6.73 billion by 2031, from an estimated $4.28 billion in 2024, at a CAGR of 6.7% during the forecast period 2024-2031.

Insulin Pens Market Size & Forecast